Diversified Other Liab from 2010 to 2024

DHCNL Stock  USD 15.89  0.05  0.32%   
Diversified Healthcare Other Liabilities yearly trend continues to be quite stable with very little volatility. Other Liabilities may rise above about 235.9 M this year. From the period between 2010 and 2024, Diversified Healthcare, Other Liabilities regression line of its data series had standard deviation of  34,887,397 and standard deviation of  34,887,397. View All Fundamentals
 
Other Liabilities  
First Reported
2010-12-31
Previous Quarter
219.9 M
Current Value
235.9 M
Quarterly Volatility
34.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Diversified Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diversified Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 304.6 M, Selling General Administrative of 30.3 M or Total Revenue of 1.5 B, as well as many indicators such as Price To Sales Ratio of 0.6, Dividend Yield of 0.0102 or PTB Ratio of 0.36. Diversified financial statements analysis is a perfect complement when working with Diversified Healthcare Valuation or Volatility modules.
  
Check out the analysis of Diversified Healthcare Correlation against competitors.

Latest Diversified Healthcare's Other Liab Growth Pattern

Below is the plot of the Other Liab of Diversified Healthcare Trust over the last few years. It is Diversified Healthcare's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Diversified Healthcare's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Diversified Other Liab Regression Statistics

Arithmetic Mean278,929,073
Geometric Mean276,808,812
Coefficient Of Variation12.51
Mean Deviation32,086,179
Median304,220,000
Standard Deviation34,887,397
Sample Variance1217.1T
Range104.5M
R-Value(0.83)
Mean Square Error407.8T
R-Squared0.69
Significance0.0001
Slope(6,474,731)
Total Sum of Squares17039.8T

Diversified Other Liab History

2024235.9 M
2023219.9 M
2019244.3 M
2018306 M
2017324.3 M
2016295.4 M

About Diversified Healthcare Financial Statements

Diversified Healthcare investors utilize fundamental indicators, such as Other Liab, to predict how Diversified Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities219.9 M235.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Diversified Healthcare is a strong investment it is important to analyze Diversified Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Diversified Healthcare's future performance. For an informed investment choice regarding Diversified Stock, refer to the following important reports:
Check out the analysis of Diversified Healthcare Correlation against competitors.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Diversified Healthcare. If investors know Diversified will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Diversified Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.68)
Revenue Per Share
6.324
Quarterly Revenue Growth
0.541
Return On Assets
0.0124
Return On Equity
(0.06)
The market value of Diversified Healthcare is measured differently than its book value, which is the value of Diversified that is recorded on the company's balance sheet. Investors also form their own opinion of Diversified Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Diversified Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Diversified Healthcare's market value can be influenced by many factors that don't directly affect Diversified Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Diversified Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Diversified Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Diversified Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.